Document Detail


Serum lipids, blood pressure, body weight, and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin ST 1435.
MedLine Citation:
PMID:  1407928     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To study the changes in serum lipids, serum chemistry, blood pressure, and body weight in long-term users of subcutaneous contraceptive implants releasing the progestin ST 1435. METHODS: The study was done in the outpatient clinic of the City Maternity Hospital, Helsinki, Finland. Subdermal implants releasing the progestin ST 1435 were inserted in 30 women for 2 years of use. Healthy women aged 19-35 used the implants for contraception. Measurements of body weight and blood pressure were made and blood samples for lipid analysis (total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides) and serum chemistry were taken before insertion of the implants and every 6 months thereafter until removal. Results are reported for 30 subjects after 6 months of use, 25 subjects after 12 months, 13 after 18 months, and 12 after 24 months. RESULTS: Blood pressure and serum chemistry, ie, liver enzymes and electrolytes, remained unchanged. Slight weight gain occurred, but was not statistically significant. No statistically significant changes were found in lipids or lipid ratios when comparing the values during use of the implant with the pre-treatment values. CONCLUSIONS: The progestin ST 1435, used parenterally for contraception or progestin therapy, had no adverse effects on serum lipids, blood pressure, or body weight, which are known to be risk factors for coronary artery disease. The steroid had no effects on serum chemistry determinations in long-term use.
Authors:
M Laurikka-Routti
Related Documents :
10204818 - Effect of hydrosoluble coenzyme q10 on blood pressures and insulin resistance in hypert...
1381018 - Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
8665108 - Resistance trained athletes using or not using anabolic steroids compared to runners: e...
15867138 - Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid ...
8476098 - Acute resetting of the carotid sinus baroreflex by aortic depressor nerve stimulation.
113018 - Comparative study of nitroglycerin and molsidomine. effects on the integrated systemic ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  80     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1992 Nov 
Date Detail:
Created Date:  1992-11-13     Completed Date:  1992-11-13     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  855-9     Citation Subset:  AIM; IM    
Affiliation:
City Maternity Hospital, Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure / drug effects*
Body Weight / drug effects*
Cholesterol / blood
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Contraceptive Agents, Female / pharmacology*
Drug Implants
Female
Humans
Lipids / blood*
Norprogesterones / pharmacology*
Time Factors
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Contraceptive Agents, Female; 0/Drug Implants; 0/Lipids; 0/Norprogesterones; 0/Triglycerides; 57-88-5/Cholesterol; 7759-35-5/ST 1435

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Morning sickness control in early pregnancy by Neiguan point acupressure.
Next Document:  Sexual assault in postmenopausal women.